I do not think the situation is all bad news at the moment The Oraline project has not been abandonded and the following statement from the announcement appears positive: "The Company also remains on track with the development of a new dual strip version of Oraline® and will be updating the market as we progress. The release of this and upcoming versions of Oraline® are well timed to capitalise on a worldwide trend towards convenient saliva based occupational drug testing " Kens
SBN Price at posting:
0.8¢ Sentiment: None Disclosure: Held